The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vercellotti, G. M.
Right arrow Articles by Dalmasso, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vercellotti, G. M.
Right arrow Articles by Dalmasso, A. P.

The Journal of Immunology, Vol 146, Issue 2 730-734, Copyright © 1991 by American Association of Immunologists


ARTICLES

Neutrophil adhesion to xenogeneic endothelium via iC3b

GM Vercellotti, JL Platt, FH Bach and AP Dalmasso
Department of Medicine, Minneapolis VA Hospital, MN.

Neutrophils are thought to play an important role in the pathogenesis of hyperacute rejection, a dramatic form of tissue injury caused by the reaction of antigraft antibodies with endothelial cells of an organ allograft or xenograft. We asked whether the interactions of human polymorphonuclear leucocytes (PMN) with xenogeneic endothelium might be promoted by the binding of natural anti-endothelial antibodies and complement by using porcine aortic endothelial cells (PAEC), human serum, and human PMN in an in vitro model of hyperacute rejection. Pretreatment of PAEC with 10% human serum followed by washing markedly increased PMN adhesion from 15.7 +/- 1.8% to 62.5 +/- 3.6% (p less than 0.001). Complement and anti-endothelial antibodies were necessary for the increase, because heat-inactivated serum or serum depleted of IgM did not significantly increase PMN adhesion to treated endothelium. The induction of increased PMN adhesion to PAEC by human serum was observed within 1 min. The essential role of complement was defined using complement-depleted serum. Ten percent C2-deficient serum did not increase PMN adhesion whereas 10% C5-depleted or 10% C8-depleted serum caused the same increase in PMN adhesion as observed with normal human serum. These results suggested that C3 might play a critical role in enhanced neutrophil adhesion. In fact, PAEC treated with 10% human serum for 15 min and incubated with an F(ab')2 antihuman C3 for 10 min completely abolished the enhanced adhesion. PAEC treated with 10% human serum or C5-depleted serum displayed fluorescence of iC3b whereas monolayers treated with heat-inactivated serum or C2-deficient serum were non-reactive. The enhanced PMN adhesion to serum-treated PAEC was mediated through neutrophil receptors binding iC3b because mAb directed against CD11b/CD18 inhibited the serum-enhanced adhesion of PMN. We conclude that PMN adhesion to endothelium can be significantly enhanced by the endothelial deposition of iC3b.


This article has been cited by other articles:


Home page
FASEB J.Home page
S. SAADI, L. E. WRENSHALL, and J. L. PLATT
Regional manifestations and control of the immune system
FASEB J, June 1, 2002; 16(8): 849 - 856.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Fox-Marsh and L. C. Harrison
Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system
J. Leukoc. Biol., March 1, 2002; 71(3): 401 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. MORIGI, C. ZOJA, S. COLLEONI, S. ANGIOLETTI, B. IMBERTI, R. DONADELLI, A. REMUZZI, and G. REMUZZI
Xenogeneic Serum Promotes Leukocyte-Endothelium Interaction under Flow through Two Temporally Distinct Pathways: Role of Complement and NuclearFactor-{kappa}B
J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2197 - 2207.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Buerke, D. Prüfer, M. Dahm, H. Oelert, J. Meyer, and H. Darius
Blocking of Classical Complement Pathway Inhibits Endothelial Adhesion Molecule Expression and Preserves Ischemic Myocardium from Reperfusion Injury
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 429 - 438.
[Abstract] [Full Text]


Home page
CirculationHome page
C. D. Collard, A. Vakeva, C. Bukusoglu, G. Zund, C. J. Sperati, S. P. Colgan, and G. L. Stahl
Reoxygenation of Hypoxic Human Umbilical Vein Endothelial Cells Activates the Classic Complement Pathway
Circulation, July 1, 1997; 96(1): 326 - 333.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Buerke, T. Murohara, and A. M. Lefer
Cardioprotective Effects of a C1 Esterase Inhibitor in Myocardial Ischemia and Reperfusion
Circulation, January 15, 1995; 91(2): 393 - 402.
[Abstract] [Full Text]


Home page
LupusHome page
Y. Adler, K. Salozhin, M. Le Tonqueze, Y. Shoenfeld, and P. Youinou
Review: Anti-Endothelial Cell Antibodies: a Need for Standardization
Lupus, April 1, 1994; 3(2): 77 - 84.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.